Abstract
Asthma is a chronic inflammatory disease characterized by bronchial hyper-reactivity to various stimuli, culminating with bronchospasm crises. Poorly controlled asthma during pregnancy can lead to hypoxia and the consequent increase in maternal and perinatal mortality, prematurity and fetal growth retardation, hyperemesis, and preeclampsia. The course of asthma during pregnancy is not predictable and improvements, worsening, or stabilization of the framework can occur. The treatment of asthma during pregnancy is similar to the usual treatment. The main objectives of treatment are: to control symptoms by avoiding fetal hypoxia, guide the pregnant women about symptoms and how to avoid triggering factors, treatment of crises and maintenance of a normal or near-normal lung function. Asthma during pregnancy should be monitored monthly, with spirometry in the first prenatal consultation and evaluation of peak flow (peak-flow) in subsequent consultations. The medicines used for asthma are divided into two categories: medications for improving a crisis (acute symptoms) and maintenance medications (avoiding exacerbations-controlling symptoms). The ultrasound should be performed early for adequate pregnancy dating enabling appropriate follow-up of fetal growth. Serial exams on the 2nd and 3rd trimesters are essential if the pregnant woman has moderate or severe
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
